🔎 Trials Near Me

Akèy › Amiloidoz ereditè ki gen rapò ak transthyretin › Ohio › Cleveland

Etid klinik pou Amiloidoz ereditè ki gen rapò ak transthyretin nan Cleveland, OH

3 etid pou Amiloidoz ereditè ki gen rapò ak transthyretin ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Ap rekriteEtid obsèvasyon
  • Cleveland Clinic, Cleveland
Laj 30 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT05489549

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Ap rekriteFaz 3
  • Cleveland Clinic, Cleveland
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

Ap rekriteFaz 3
  • Cleveland Clinic, Cleveland
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629

Etid Amiloidoz ereditè ki gen rapò ak transthyretin nan lòt vil

Lòt etid nan Cleveland

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.